Michael Landberg, strategic global sourcing manager at Boston Scientific, describes how a major player in life-sciences approaches the critical issue of risk management.
Pfizer will build a biologics plant in China, where it will make biosimilars for the Chinese market but also for sale throughout the world. The New York drugmaker has turned to GE for construction of the facility, which has developed a modular construction process that will cut the cost and allow the plant to be operational in about 18 months, instead of three years.
Shipping and logistics operators say the U.K. vote to leave the European Union will rattle regional supply chains as Britain rebuilds its trading relationships and rules.
As larger U.S. retailers continue to close underperforming stores with more customers choosing to shop online from their own homes, big-box store vacancies have increased in recent years. But with online sales only increasing and more small shop spaces mimicking the online sales environment, the biggest impacts are being reflected in warehouse space and logistics.
The Panama Canal accounts for roughly five percent of world sea trade, and the expanded Panama Canal is estimated to generate a three percent increase in cargo volumes transiting the canal.
Danish shipping and oil group A.P. Moller-Maersk could be split up into separate companies, its chairman said on Thursday after naming Soren Skou, the head of its container business, as chief executive.
Challenge: A pharmaceutical company's existing manual pick/pass picking system was constrained due to unbalanced workload across the operation — flooding some zones while others had no orders to pick.